October 15, 2026
Estuary Biotherapeutics
Estuary Biotherapeutics is a developer of gene therapies for kidney disease.
- Round
- Seed
- Amount raised
- $103M
- Lead investor
- RA Capital Management
- Industry
- Biotechnology
- Headquarters
- San Francisco
- Employees
- 11-50 employees
- Website
- estuarybio.com
- View profile →
Other investors
- 4BIO Capital
- GV
- Deep Track Capital
- Biogen New Ventures
- UPMC Enterprises
Source: Axios Pro Rata